COMMUNIQUÉS West-GlobeNewswire

-
Phase 1 Expansion Cohort Oral Presentations for Flotetuzumab, MacroGenics’ CD123 x CD3 DART® Molecule, in Relapsed/Refractory Acute Myeloid Leukemia Presented at 60th ASH Annual Meeting
04/12/2018 -
National Rheumatology and Psoriasis Organizations Release Joint Guideline for Treating Psoriatic Arthritis
03/12/2018 -
Biocartis Group NV: Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla(TM) Oncotype DX Genomic Prostate Score® Test
03/12/2018 -
Osmotica Pharmaceuticals to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
03/12/2018 -
Geron Announces New Overall Survival Data from IMbark in Imetelstat-Treated Patients with Intermediate-2 or High-Risk Myelofibrosis and Relapsed/Refractory to Janus Kinase Inhibitor Therapy
03/12/2018 -
Diversicare Completes Sale of Three Skilled Nursing Facilities in Kentucky
03/12/2018 -
Adverum Biotechnologies Appoints Mike Fitzgerald as Vice President, Human Resources
03/12/2018 -
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
03/12/2018 -
Scholar Rock Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for SRK-015 for the Treatment of Spinal Muscular Atrophy
03/12/2018 -
Momenta Pharmaceuticals Provides Update on US Regulatory Strategy for M923, Proposed Biosimilar to HUMIRA®
03/12/2018 -
Paratek Pharmaceuticals Files Two Patent Term Extensions in the United States; Expects NUZYRA™ Patent Protection Exclusivity Until at Least October 2030
03/12/2018 -
University Medical Centre Groningen chooses TAT-5000 of Exergen Medical as standard thermometer throughout hospital
03/12/2018 -
Nextech and Red Spot Interactive Partner to Enhance Provider Retention and Patient Acquisition
03/12/2018 -
INNATE PHARMA : Updated results that support advancement of IPH4102 in refractory Sézary syndrome at ASH 2018
03/12/2018 -
INNATE PHARMA : ASH, présentation de résultats d'IPH4102 chez les patients présentant un syndrome de Sézary réfractaire et poursuite du développement en phase II dans les lymphomes de type T
03/12/2018 -
BeiGene Presents Clinical Results of Tislelizumab in Relapsed/Refractory Classical Hodgkin’s Lymphoma at the 60th American Society of Hematology Annual Meeting
03/12/2018 -
Hybrigenics (ALHYG) : Moonstone Investments a soumis une proposition de transaction, sous conditions suspensives.
03/12/2018 -
CAPS® Teams with Kit Check to Add Serialized Radio Frequency Identification (RFID) Tags on Pre-Filled Syringes
03/12/2018 -
Exeter Hospital joins North American Partners in Anesthesia
03/12/2018
Pages